MJoTAtalks

Dr Susanna's guide to

www.MJoTA.org
click here

www.MJoTAtalks.org click here

www.drsusanna.org click here



Dr Susanna loves the countries and the peoples of Africa
 
Bookmark and Share
Diabetes news from the American Diabetes Association

Latest Top (20) News
Diabetes News
Diabetes news from the National Institutes of Health Diabetes Educators.

Latest Top (10) News
Clinical trials testing therapies for diabetes

Latest Top (10) News


Beta Glucan and Acetate Production
Conditions:   Pre Diabetes;   Obesity
Interventions:   Dietary Supplement: beta glucan and resistant starch;   Dietary Supplement: Placebo;   Dietary Supplement: beta gluten
Sponsor:   Maastricht University Medical Center
Recruiting

Mon, 22 Oct 2018 12:00:00 EDT


Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients
Condition:   Kidney Transplant
Intervention:   Drug: Tacrolimus Extended Release Oral Tablet [Envarsus] 0.13mg/kg/day initiated within post-operative day 3 after kidney transplant
Sponsors:   Temple University;   Veloxis Pharmaceuticals
Not yet recruiting

Mon, 22 Oct 2018 12:00:00 EDT


Effects of Dapagliflozin+Saxagliptin in Addition to Metformin v/s Saxagliptin or Dapagliflozin in Patients With DM2.
Condition:   Glucose, Low Blood
Interventions:   Drug: Dapagliflozin 10mg;   Drug: Saxagliptin 5mg;   Drug: Saxagliptin 5mg + Dapagliflozin 10 mg
Sponsor:   University of Pisa
Recruiting

Mon, 22 Oct 2018 12:00:00 EDT


Effects of Pilates Exercise Program in Patients With Schizophrenia
Condition:   Schizophrenia
Interventions:   Other: Pilates exercise group;   Other: Control Group
Sponsor:   Hacettepe University
Completed

Mon, 22 Oct 2018 12:00:00 EDT


Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Basal Insulin Alone or in Combination With Oral Antidiabetic Drug(s)
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Efpeglenatide SAR439977;   Drug: Placebo;   Drug: Insulin glargine
Sponsor:   Sanofi
Not yet recruiting

Mon, 22 Oct 2018 12:00:00 EDT


Investigating the Effect of Onyx Sorghum on Blood Glucose in Individuals With Type 2 Diabetes
Condition:   Diabetes Type 2
Interventions:   Dietary Supplement: onyx sorghum;   Dietary Supplement: whole wheat flour
Sponsor:   Yale University
Not yet recruiting

Mon, 22 Oct 2018 12:00:00 EDT


Investigation of an Amino Acid Supplement on Glucose Levels in Obese Subjects
Conditions:   Pre-diabetes;   Obese;   Glucose Intolerance
Intervention:   Dietary Supplement: BCAA
Sponsor:   University of California, Los Angeles
Completed

Mon, 22 Oct 2018 12:00:00 EDT


The Effect of Cognitive Behavioral Therapy for Insomnia on Type 2 Diabetes Health Outcomes
Conditions:   Type2 Diabetes;   Insomnia
Interventions:   Behavioral: Cognitive behavioral therapy for insomnia;   Other: Health Education
Sponsor:   University of Kansas Medical Center
Not yet recruiting

Mon, 22 Oct 2018 12:00:00 EDT


Benefits of Standard ONS in Indian Adults
Condition:   Poor Nutrition
Intervention:   Other: Oral Nutritional Supplement (ONS)
Sponsor:   Abbott Nutrition
Not yet recruiting

Fri, 19 Oct 2018 12:00:00 EDT


Comparison of FDG PET and Bone Scintigraphy/Labelled Leukocyte/Gallium Scintigraphy in Diabetic Foot Osteomyelitis
Condition:   Diabetic Foot Infection
Intervention:   Diagnostic Test: 18F-FDG PET-CT
Sponsor:   Centre hospitalier de l'Université de Montréal (CHUM)
Not yet recruiting

Fri, 19 Oct 2018 12:00:00 EDT
Don't get diabetes! Take care of yourself if you have it! Diabetes resources, click here.
FDA (Food and Drug Administration) press releases. FDA makes sure of the safety of all medicines which can be injected, breathed in, rubbed in and swallowed, in the United States of America.

Latest Top (10) News


Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death
Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s ongoing commitment to improving efficiency, transparency of tobacco product application review process as part of FDA’s comprehensive framework to reduce tobacco-related disease and death.

Mon, 22 Oct 2018 09:29:00 -0400


Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, processors more effectively comply with food safety requirements
Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to help produce farmers, fresh-cut produce processors more effectively comply with food safety requirements

Fri, 19 Oct 2018 09:55:00 -0400


Trump Administration Launches “Winning on Reducing Food Waste” Initiative
The U.S. Department of Agriculture (USDA), the U.S. Environmental Protection Agency (EPA), and the U.S. Food and Drug Administration (FDA) today announced the signing of a joint agency formal agreement under the "Winning on Reducing Food Waste" initiative.

Thu, 18 Oct 2018 17:01:00 -0400


FDA and DHS increase coordination of responses to medical device cybersecurity threats under new partnership; a part of the two agencies’ broader effort to protect patient safety
FDA and DHS announce partnership to address medical device cybersecurity threats

Tue, 16 Oct 2018 16:42:00 -0400


Statement by FDA Commissioner Scott Gottlieb, M.D., on FDA’s new steps to modernize drug development, improve efficiency and promote innovation of targeted therapies
FDA issues two guidance documents to provide drug developers greater clarity and direction as they pursue the next generation of therapies and treatments for patients.

Mon, 15 Oct 2018 10:33:00 -0400


FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy
FDA advances investigation into whether more than 40 e-cigarette products are being illegally marketed and outside agency's compliance policy

Fri, 12 Oct 2018 10:11:00 -0400


FDA approves new DNA-based test to determine blood compatibility
FDA approves new DNA-based test to determine blood compatibility.Test is first of this type approved to report genotypes as final results

Thu, 11 Oct 2018 16:32:00 -0400


La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad
La FDA aprueba el uso ampliado de Gardasil 9 para incluir a personas de 27 a 45 años de edad

Tue, 09 Oct 2018 17:16:00 -0400


Statement from FDA Commissioner Scott Gottlieb, M.D., on new efforts to advance the development of generic copies of complex drugs to improve patient access to medicines
FDA issued a new series of guidance documents that will advance the development of generic transdermal and topical delivery systems

Tue, 09 Oct 2018 09:34:00 -0400


FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old
FDA approves expanded use of Gardasil 9 to include individuals 27 through 45 years old

Fri, 05 Oct 2018 16:48:00 -0400